---
figid: PMC4102744__jgo-25-249-g001
figlink: /pmc/articles/PMC4102744/figure/F1/
number: Fig. 1
caption: 'Cytoplasmic/traditional and nuclear modes of the epidermal growth factor
  receptor (EGFR) signalling pathway. The EGFR signalling pathway exerts its biological
  effects via two major modes of actions, namely, cytoplasmic/traditional (A) and
  nuclear (B) modes. (A) The cytoplasmic EGFR pathway is consisted of four major modules:
  PLC-γ-CaMK/PKC, Ras-Raf-MAPK, PI-3K-Akt-GSK and signal transducer and activator
  of transcriptions (STATs). Activation of these signalling modules often leads to
  tumorigenesis, tumour proliferation, metastasis, chemoresistance and radioresistance.
  (B) The nuclear EGFR pathway can be initiated by ligand binding and exposure to
  vitamin D, radiation, cisplatin, heat and H2O2. Following nuclear translocalization,
  nuclear EGFR interacts with DNA-binding transcription factors, E2F1 and STAT3, and
  activates expression of B-Myb and inducible nitric oxide synthase (iNOS), respectively.
  Nuclear EGFR also upregulates cyclin D1 gene expression. Increased expression of
  cyclin D1 and B-Myb contributes to accelerated G1/S cell cycle progression and,
  on the other hand, elevated iNOS is associated with tumour proliferation and metastasis.
  Upon DNA damage and oxidative/heat stress, EGFR enters the cell nucleus and interacts
  with DNA-PK, leading to DNA repair and radioresistance. Reprinted from Lo and Hung
  [].'
pmcid: PMC4102744
papertitle: 'Beyond angiogenesis blockade: targeted therapy for advanced cervical
  cancer.'
reftext: Ramez N. Eskander, et al. J Gynecol Oncol. 2014 Jul;25(3):249-259.
pmc_ranked_result_index: '7492'
pathway_score: 0.9533811
filename: jgo-25-249-g001.jpg
figtitle: Cytoplasmic/traditional and nuclear modes of the epidermal growth factor
  receptor (EGFR) signalling pathway
year: '2014'
organisms: Homo sapiens
ndex: 2b7085d4-deb6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4102744__jgo-25-249-g001.html
  '@type': Dataset
  description: 'Cytoplasmic/traditional and nuclear modes of the epidermal growth
    factor receptor (EGFR) signalling pathway. The EGFR signalling pathway exerts
    its biological effects via two major modes of actions, namely, cytoplasmic/traditional
    (A) and nuclear (B) modes. (A) The cytoplasmic EGFR pathway is consisted of four
    major modules: PLC-γ-CaMK/PKC, Ras-Raf-MAPK, PI-3K-Akt-GSK and signal transducer
    and activator of transcriptions (STATs). Activation of these signalling modules
    often leads to tumorigenesis, tumour proliferation, metastasis, chemoresistance
    and radioresistance. (B) The nuclear EGFR pathway can be initiated by ligand binding
    and exposure to vitamin D, radiation, cisplatin, heat and H2O2. Following nuclear
    translocalization, nuclear EGFR interacts with DNA-binding transcription factors,
    E2F1 and STAT3, and activates expression of B-Myb and inducible nitric oxide synthase
    (iNOS), respectively. Nuclear EGFR also upregulates cyclin D1 gene expression.
    Increased expression of cyclin D1 and B-Myb contributes to accelerated G1/S cell
    cycle progression and, on the other hand, elevated iNOS is associated with tumour
    proliferation and metastasis. Upon DNA damage and oxidative/heat stress, EGFR
    enters the cell nucleus and interacts with DNA-PK, leading to DNA repair and radioresistance.
    Reprinted from Lo and Hung [].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND1
  - PIK3R3
  - PIK3R5
  - HRAS
  - PRKDC
  - PIK3CG
  - PIK3CA
  - NRAS
  - STAT3
  - KRAS
  - EGF
  - GNAL
  - GNAS
  - MYBL2
  - PIK3CB
  - PIK3R6
  - EGFR
  - E2F1
  - PIK3R4
  - PIK3CD
  - cisplatin
  - vitamin D
  - Cancer
genes:
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: DNA-PK
  symbol: DNAPK
  source: hgnc_alias_symbol
  hgnc_symbol: PRKDC
  entrez: '5591'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: B-Myb
  symbol: B-MYB
  source: hgnc_alias_symbol
  hgnc_symbol: MYBL2
  entrez: '4605'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: E2F1
  symbol: E2F1
  source: hgnc_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals:
- word: cisplatin
  source: MESH
  identifier: D002945
- word: vitamin D
  source: MESH
  identifier: D014807
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
